Free Trial

Chinese Stocks To Research - October 11th

Diageo logo with Consumer Staples background

Key Points

  • The three Chinese stocks recommended for research are Diageo, UP Fintech, and Regencell Bioscience, which have shown the highest dollar trading volume recently.
  • Diageo operates in the alcoholic beverage sector, offering a variety of products including whisky and beer.
  • UP Fintech focuses on providing online brokerage services to Chinese investors, while Regencell Bioscience is dedicated to traditional Chinese medicine for treating neurocognitive disorders.
  • MarketBeat previews top five stocks to own in November.

Diageo, UP Fintech, and Regencell Bioscience are the three Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are equity securities of companies domiciled in China or deriving a significant portion of their revenue from the Chinese market. They trade on domestic exchanges like Shanghai and Shenzhen (often as A-shares or B-shares) or on overseas venues such as Hong Kong (H-shares) and U.S. exchanges via American depositary receipts. Investors buy them to gain exposure to China’s economic growth across sectors ranging from technology and consumer goods to industrials. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Read Our Latest Research Report on TIGR

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Read Our Latest Research Report on RGC

Recommended Stories

Should You Invest $1,000 in Diageo Right Now?

Before you consider Diageo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diageo wasn't on the list.

While Diageo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.